148 related articles for article (PubMed ID: 30997554)
1. Capability of iturin from Bacillus subtilis to inhibit Candida albicans in vitro and in vivo.
Lei S; Zhao H; Pang B; Qu R; Lian Z; Jiang C; Shao D; Huang Q; Jin M; Shi J
Appl Microbiol Biotechnol; 2019 Jun; 103(11):4377-4392. PubMed ID: 30997554
[TBL] [Abstract][Full Text] [Related]
2. Lipopeptides from Bacillus strain AR2 inhibits biofilm formation by Candida albicans.
Rautela R; Singh AK; Shukla A; Cameotra SS
Antonie Van Leeuwenhoek; 2014 May; 105(5):809-21. PubMed ID: 24623107
[TBL] [Abstract][Full Text] [Related]
3. Bacillus subtilis inhibits Aspergillus carbonarius by producing iturin A, which disturbs the transport, energy metabolism, and osmotic pressure of fungal cells as revealed by transcriptomics analysis.
Jiang C; Li Z; Shi Y; Guo D; Pang B; Chen X; Shao D; Liu Y; Shi J
Int J Food Microbiol; 2020 Oct; 330():108783. PubMed ID: 32659523
[TBL] [Abstract][Full Text] [Related]
4. Antifungal activity of silver nanoparticles synthesized by iturin against Candida albicans in vitro and in vivo.
Zhou L; Zhao X; Li M; Lu Y; Ai C; Jiang C; Liu Y; Pan Z; Shi J
Appl Microbiol Biotechnol; 2021 May; 105(9):3759-3770. PubMed ID: 33900424
[TBL] [Abstract][Full Text] [Related]
5. Synthesis, characterization and antifungal activity of a novel formulated nanocomposite containing Indolicidin and Graphene oxide against disseminated candidiasis.
Farzanegan A; Roudbary M; Falahati M; Khoobi M; Gholibegloo E; Farahyar S; Karimi P; Khanmohammadi M
J Mycol Med; 2018 Dec; 28(4):628-636. PubMed ID: 30126717
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic effect of iturin A on
Han D; Ji Y; Yang S; Song P; Shi Y; Shao D; Chen X; Shang L; Shi J; Jiang C
Antimicrob Agents Chemother; 2024 Jan; 68(1):e0094823. PubMed ID: 38051047
[No Abstract] [Full Text] [Related]
7. Evaluation of Antifungal Efficacy of Three New Cyclic Lipopeptides of the Class Bacillomycin from Bacillus subtilis RLID 12.1.
Ramachandran R; Shrivastava M; Narayanan NN; Thakur RL; Chakrabarti A; Roy U
Antimicrob Agents Chemother; 2018 Jan; 62(1):. PubMed ID: 29038271
[TBL] [Abstract][Full Text] [Related]
8. Antifungal activity of amphotericin B and voriconazole against the biofilms and biofilm-dispersed cells of Candida albicans employing a newly developed in vitro pharmacokinetic model.
El-Azizi M; Farag N; Khardori N
Ann Clin Microbiol Antimicrob; 2015 Apr; 14():21. PubMed ID: 25885806
[TBL] [Abstract][Full Text] [Related]
9. Synergistic Antifungal Effect of Amphotericin B-Loaded Poly(Lactic-Co-Glycolic Acid) Nanoparticles and Ultrasound against Candida albicans Biofilms.
Yang M; Du K; Hou Y; Xie S; Dong Y; Li D; Du Y
Antimicrob Agents Chemother; 2019 Apr; 63(4):. PubMed ID: 30670414
[No Abstract] [Full Text] [Related]
10. Assessing the potential of four cathelicidins for the management of mouse candidiasis and Candida albicans biofilms.
Yu H; Liu X; Wang C; Qiao X; Wu S; Wang H; Feng L; Wang Y
Biochimie; 2016 Feb; 121():268-77. PubMed ID: 26656137
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of T-2307, a novel arylamidine, against ocular complications of disseminated candidiasis in mice.
Abe M; Nakamura S; Kinjo Y; Masuyama Y; Mitsuyama J; Kaku M; Miyazaki Y
J Antimicrob Chemother; 2019 May; 74(5):1327-1332. PubMed ID: 30753506
[TBL] [Abstract][Full Text] [Related]
12. Effects of ambroxol on Candida albicans growth and biofilm formation.
Rene HD; José MS; Isela SN; Claudio CR
Mycoses; 2014 Apr; 57(4):228-32. PubMed ID: 24224742
[TBL] [Abstract][Full Text] [Related]
13. Quercetin Assists Fluconazole to Inhibit Biofilm Formations of Fluconazole-Resistant Candida Albicans in In Vitro and In Vivo Antifungal Managements of Vulvovaginal Candidiasis.
Gao M; Wang H; Zhu L
Cell Physiol Biochem; 2016; 40(3-4):727-742. PubMed ID: 27915337
[TBL] [Abstract][Full Text] [Related]
14. Antifungal activity against planktonic and biofilm Candida albicans in an experimental model of foreign-body infection.
Maiolo EM; Oliva A; Furustrand Tafin U; Perrotet N; Borens O; Trampuz A
J Infect; 2016 Mar; 72(3):386-92. PubMed ID: 26723911
[TBL] [Abstract][Full Text] [Related]
15. Unexplored antifungal activity of linear battacin lipopeptides against planktonic and mature biofilms of C. albicans.
De Zoysa GH; Glossop HD; Sarojini V
Eur J Med Chem; 2018 Feb; 146():344-353. PubMed ID: 29407961
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of liposomal amphotericin B against four species of Candida biofilms in an experimental mouse model of intravascular catheter infection.
Fujimoto K; Takemoto K
J Infect Chemother; 2018 Dec; 24(12):958-964. PubMed ID: 30209024
[TBL] [Abstract][Full Text] [Related]
17. Development of
Lee HS; Kim Y
J Microbiol Biotechnol; 2018 Mar; 28(3):482-490. PubMed ID: 29316739
[No Abstract] [Full Text] [Related]
18. 5-hydroxymethyl-2-furaldehyde from marine bacterium Bacillus subtilis inhibits biofilm and virulence of Candida albicans.
Subramenium GA; Swetha TK; Iyer PM; Balamurugan K; Pandian SK
Microbiol Res; 2018 Mar; 207():19-32. PubMed ID: 29458854
[TBL] [Abstract][Full Text] [Related]
19. Lysine enhances the effect of amphotericin B against Candida albicans in vitro.
Zhao L; Jiang J; Zhu Z; Liao Z; Yao X; Yang Y; Cao Y; Jiang Y
Acta Biochim Biophys Sin (Shanghai); 2016 Feb; 48(2):182-93. PubMed ID: 26711896
[TBL] [Abstract][Full Text] [Related]
20. Comparative effects of cilofungin and amphotericin B on experimental murine candidiasis.
Morrison CJ; Stevens DA
Antimicrob Agents Chemother; 1990 May; 34(5):746-50. PubMed ID: 2193617
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
